Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind trial of Chaigetuire Keli for common cold (exogenous cold with internal heat pattern)
CTR20243269Phase 2Completed
- Sponsor
- Kaijin Biotech
- Start
- Aug 2024
- Countries
- 1
01
Overview
A Phase 2 trial of Chaigetuire Keli in nasopharyngitis, sponsored by Kaijin Biotech. Started Aug 2024; status: completed.
02
Drugs
Chaigetuire Keli
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on CTR20243269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243269.